CD36 and colon adenocarcinoma: Through bioinformatics methods, CD36 was found to be associated with lipid metabolism and immune response (Hao et al., 2019), and its high expression was associated with poor prognosis of COAD, and it was found that CD36 was the target of quercetin on COAD (Pang et al., 2019).